Brief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
BRIEF-Genmab Q3 Net Sales Of Darzalex At $4.24 Bln Oct 13 (Reuters) - Genmab A/S GMAB.CO:
GENMAB ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR THIRD QUARTER OF 2026
DARZALEX Q3 2026 NET SALES TOTAL USD 4.24 BILLION
DARZALEX Q3 2026 NET SALES USD 2.53 BILLION IN U.S., USD 1.71 BILLION REST OF WORLD
Source text: ID:nGNEbPDJz0
Further company coverage: GMAB.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos